Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00985231 · ClinicalTrials.gov registry record · NA
Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 272
- Enrollment target
NCT00985231 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 272 participants.
The verdict
NCT00985231, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 272 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate Bausch \& Lomb PureVision Multi-Focal contact lenses compared to the Bausch \& Lomb SofLens59 contact lens when worn by adapted soft contact lens wearers on a daily wear basis.
Interventions
- DEVICE PureVision Multi-Focal contact lenses
- DEVICE SofLens59 contact lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2009-09 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00985231
The ClinicalTrials.gov registry entry for NCT00985231 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PureVision Multi-Focal contact lenses is the first listed.
NCT00985231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00985231 about?
NCT00985231 is a clinical study titled "Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers". This study is being conducted to evaluate Bausch \& Lomb PureVision Multi-Focal contact lenses compared to the Bausch \& Lomb SofLens59 contact lens when worn by adapted soft contact lens wearers on a daily wear basis.
What is the current status of trial NCT00985231?
This trial is currently completed. It is a NA study. The enrollment target is 272 participants. The study started on 2009-09. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00985231?
The interventions under investigation include: PureVision Multi-Focal contact lenses (DEVICE), SofLens59 contact lens (DEVICE).
Who is sponsoring clinical trial NCT00985231?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.